This year’s roundup of bad behavior in the life sciences and new initiatives to prevent misconduct
The Scientist
Most Recent
An official investigation into a controversial GM rice study carried out with Chinese schoolchildren has resulted in the removal of three China-based researchers.
In the latest effort to boost publication records, researchers are writing positive peer reviews for their work under other scientists’ names.
An analyst that worked for a state drug lab in Massachusetts has confessed to mishandling evidence in tens of thousands of drug cases.
Will the recently launched Reproducibility Initiative succeed in cleaning up research and reducing retractions?
The Office of Research integrity sanctions a Joslin Diabetes Center researcher for fudging data in retracted papers.
A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.
A new initiative offers gold stars to researchers willing to have their studies replicated by other labs, but will it fix science’s growing irreproducibility problem?
Charles Nemeroff, who was barred from receiving grants for 2 years in 2008, snags $401K from the NIH to study PTSD.
An investigation of a well-known Dutch brain researcher finds evidence that she misrepresented data in 15 papers, but she is refuting the findings.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
